The Safety,Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus

NCT01342042 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

BIOLOGICAL: rExenatide-4

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Collaborators

[object Object]
[object Object]